Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

82.43
-2.4500-2.89%
Pre-market: 82.440.0100+0.01%07:02 EDT
Volume:1.00M
Turnover:82.77M
Market Cap:4.61B
PE:-20.04
High:84.85
Open:84.73
Low:81.06
Close:84.88
52wk High:117.88
52wk Low:32.22
Shares:55.93M
Float Shares:55.85M
Volume Ratio:1.25
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:3.93
PE(LYR):-19.61

Loading ...

Dianthus Therapeutics Inc Expected to Post a Loss of 86 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Dianthus Therapeutics Grants 87,000 Inducement Stock Options at $106.02 Per Share

Reuters
·
Aug 04

Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

Movement Alert|Dianthus Therapeutics Rises 9.22% in Regular Trading, Trading at $104.14

Market Focus
·
Jul 18

Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz Disposes of Common Shares Worth $3.06 Million

Reuters
·
Jul 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 06

Dianthus Therapeutics Grants 58,000 Inducement Stock Options Priced at $90.21 Per Share

Reuters
·
Jul 03

Dianthus Therapeutics - Top-line Results from Phase 3 Emerge Trial Anticipated in 2H 2028

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics - Expects Phase 2 Momentum Trial Top-line Data in Q4 2026 and Captivate Update by Ye 2026

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics SVP, General Counsel Adam Veness disposes of USD 2.42 million in common shares

Reuters
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Jun 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)

TIPRANKS
·
Jun 15

TD Cowen Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

TIPRANKS
·
Jun 14

Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James

TIPRANKS
·
Jun 13

Dianthus reports additional data from Part A of CAPTIVITY study

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 13

Dianthus rises 7.7%

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11